The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today issued the following statement in response to the Federal Trade Commission's reckless insulin action: ...
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback